ArticleProceedings of the National Academy of Sciences of the United States of America2014

PIP5K1α inhibition as a therapeutic strategy for prostate cancer.

Justin M Drake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.